Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Proteome Systems Pen Mass Spec Software Agreement

NEW YORK, April 19 (GenomeWeb News) - Agilent Technologies and Proteome Systems will collaborate on a combined platform for glycoprotein analysis, the companies said today.

 

Under the terms of the agreement, Proteome Systems will make its GlycomIQ software compatible with Agilent's XCT, XCT Plus, and XCT Ultra ion-trap mass spectrometers, the companies said.

 

Financial terms of the deal were not disclosed.

 

The companies said that the combined products are expected to be available this summer. In addition, the companies will jointly develop applications and seminars as part of the marketing agreement.

 

GlycomIQ comprises kits, consumables, and informatics software for automated analysis of protein glycosylation.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more